Clinical trial
Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute…
NCT00402259 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00402259 |
|---|---|
| Title | Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding |
| Official title | A Randomised, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study to Assess the Efficacy and Safety of Esomeprazole or Omeprazole for 5 Days in Subjects With Acute Non-Variceal Upper Gastrointestinal Bleeding |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastrointestinal Hemorrhage |
| Intervention type | Drug |
| Interventions | Esomeprazole IV, Omeprazole IV |
| Enrollment | 440 |
| Start date | Aug 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Nov 22, 2006 |
| Last update posted | Mar 12, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: